International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the  Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing more...


  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 62

PDF Downloaded: 30


Sridhar, Mohan, Rajendiran, Sekar, Singh, Nambiar, and Cassinadane: Vitamin D nemesis of COVID-19


Introduction

Vitamin D, a fat soluble prohormone required for calcium and phosphate metabolism plays a pivotal role in maintaining bone and muscle health.1 It is also involved in cellular proliferation and differentiation,2 regulating gene expression and signal transduction. Vitamin D, by binding with its receptor secures against endogenous and exogenous stresses and possess non calcaemic role like immunomodulation in regulating innate immunity and autoimmune response.3

The outbreak of COVID-19 has set in a global pandemic - a health crisis situation; thereby making it a mandate requisite to prevent the public from the jaws of corona virus infection and progression. The relationship between vitamin D deficiency and respiratory health was well-established.4 Vitamin D levels are lowered in acute or critical illness which sets in inflammatory episode. The corona virus enters the host cells through binding with angiotensin converting enzyme (ACE2) receptors in the respiratory tract.5 The virus can be eliminated at an earlier stage of infection by improving the host immune response. However strategies need to be developed to improve immune responses; one of them is to utilize a potential immunomodulator to improve individual immunity. One of the recent debates is about the use of Vitamin-D with the immunomodulator action in prevention and management of novel corona virus disease. So we aimed to study the role of vitamin D in Corona virus disease prevention and halting its progression.

Figure 1

Vitamin D role in antimicrobial action

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/7b49bd2f-7cc8-4acc-9758-e8110ae04e88image1.png

Vitamin D, otherwise known as Calciferol, is a steroid hormone produced endogenously in the skin by the effect of ultra violet (UV) radiation from the sun, through exogenous food sources or supplements. The active form of the vitamin is 1, 25-dihydroxy Calciferol (Calcitriol). Vitamin D deficiency, globally affecting 1 billion people (6), is attributed to multifactorial causes like life style modification (less outdoor time), obesity, increased use of UV-B blockers and Smog blocking UV rays. The deficiency is associated with several diseases like cancer, cardiovascular disease, infectious diseases and diabetes. Vitamin D plays a role in reducing the risk of these diseases, microbial infections and its related death, by involving three mechanisms: physical barriers, cellular natural immunity, and adaptive immunity6 as shown in Figure 1. The deficiency of Vitamin D has a predisposing effect on systemic infections and auto-immune diseases which is attributed to the immunomodulatory role of Vitamin D.7, 8

The immunomodulatory process helps in local respiratory homeostasis mechanism by two ways viz. i) promoting the expression of antimicrobial peptides, ii) directly affecting replication of respiratory viruses. It plays a regulatory role during viral infections by suppressing adaptive immune responses in respiratory epithelial cells.9 Lower levels of Vitamin D are usually correlated with increase in inflammatory cytokines and upper respiratory tract infections.10

Vitamin D receptor complex enhances the transcription of cathelicidin by acting on its gene promoter.11 Cathelicidin is involved in clearing respiratory pathogens by activating the proinflammatory cytokines, stimulating the chemotaxis of neutrophils, monocytes, macrophages, and T cells at the site of infection.12, 13 Another mechanism by which the vitamin provokes antimicrobial action is by regulating iron metabolism. Iron is required by the microbes for its survival. The vitamin inhibits hepcidin, thereby reducing intracellular iron, supressing microbial growth.14

The defence mechanism in the lung includes innate and adaptive immunity. The principal cells in the airway epithelia, alveolar macrophages, and dendritic cells express CYP27B1, which have the potential to synthesize 1,25 dihydroxy vitamin D (1,25 (OH)2D).15 These cells also express pattern recognition receptors (PRRs) that recognise the viral RNAs. 16

Vitamin D and Corona Virus Disease

Figure 2

Exploring the link between Vitamin D and COVID-19

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/7b49bd2f-7cc8-4acc-9758-e8110ae04e88image2.png

Vitamin D deficiency is regarded as a potential risk factor for coronavirus infection as suggested by many researchers.17 The evidence of association between vitamin D deficiency and COVID-19 was first pictured by Italy, the country which was severely affected by the pandemic due to its higher deficiency prevalence rate.18

Some of the mechanisms exerted by vitamin D in controlling COVID-19 include:

  1. Reduces the expression of pro-inflammatory cytokines and increases the production of antiviral proteins thereby, inhibiting viral replication.10

  2. Hindering zinc metabolism thereby decreasing viral replication.19, 20

  3. Immunomodulatory role of vitamin D by dendritic cells and T cells promotes anti-inflammatory action and viral clearance.21

  4. D vitamin adequacy is said to correlate with lower interleukin 6 levels, thereby controlling cytokine storm in severe COVID-19 infections.22, 23

However, the mild deficiency of vitamin D seem to have no effect on the corona virus disease which was shown by an UK study with 580 positive patients and 723 negative controls.24

Vitamin D levels in Disease Progression and Severity

The patients with severe COVID-19 infection requiring ICU care were vitamin D deficient as reported by Alipo M. His retrospective study with 212 covid positive cases expressed that the raise in vitamin D level to 1.63 times than the baseline would improve the clinical outcome of the critically ill patients.25 De Smet et al. in his observational study observed increasing rate of deficiency correlated with the increasing radiological evidence of disease worsening especially in covid positive male patients. This sexual dysmorphism might be due to the estrogen/androgen-dependent immune differences in both genders.26 Another retrospective study reported a mortality rate of 98.9% in vitamin deficient covid cases.27

Patients with COVID-19 are also at risk for a number of thrombotic complications and coagulopathy which is related to poor prognosis and increased mortality.28 Their serum levels of cytokines are highly increased which is associated with morbidity and mortality. Activation of innate immunity leads to increased local production of 1,25(OH)2D that amplifies viral neutralization and clearance.

Rhodes and colleagues’ review states that vitamin D deficiency correlates with severity of COVID-19 infection.29 Biesalski in his study quoted that deficiency of D vitamin is associated with comorbidities in covid patients and it increases the severity of illness in these patients.30 Severe vitamin deficiency with 25(OH)D levels below 10 ng/mL is associated with increased mortality.31 The probability of death in patients with vitamin D deficiency was 34.6% compared with 6.4% in patients with adequate vitamin D levels as shown by Alizera Abrishormi et al.32 When covid positive patients were followed up by Radujkovic et al. for a median period of 66 days, showed that Vitamin D deficiency was associated with a 6-fold higher risk for severity of disease and a 15-fold higher risk of mortality with increased oxygen requirement and requirement of intermittent ventilation.33

Figure 3

Confounding factors

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/8964848a-936b-4d26-8417-172ab9d327f0/image/7ea010c0-67a5-4045-bcfa-5721c2c070b2-u111.jpg

Table 1

Vitamin D and COVID-19 related studies

S. No

Author

Place of study

No. of Covid Patients

Inference

01

Meltzer et al 34

USA

489

Vitamin deficiency is associated with increased COVID risk

02

Pinzon et al35

Indonesia

10

Hypovitaminosis D is reported in 90% of the covid patients in the study

03

Jain et al36

India

154

Vitamin D deficiency is related to high fatality rate in corona affected patients

04

L. Hernandez37

Spain

216

Vitamin D deficient COVID-19 patients had increased prevalence of hypertension and cardiovascular diseases, raised serum ferritin and troponin levels and prolonged hospital stay

05

Alex Pizzini31

Austria

109

Severe COVID infection displays disturbed vitamin D – PTH axis

06

Antonio D Avolio38

Switzerland

27

Low Vitamin D3 concentrations are noted in SARS CoV2 patients

07

Alizera Abrishormi32

Iran

73

High levels of vitamin D is associated with lesser extent of lung involvement and low levels are associated with mortality

08

Alexandar Radujkovic33

Germany

185

Vitamin D deficiency and its association between severity and mortality of COVID-19 patients

09

Vadir Baktash39

UK

105

Increased mortality in older adults with vitamin D deficiency.

10

Faul et al40

Ireland

33

Patients with (Acute Respiratory Distress Syndrome) ARDS had low vitamin D levels

(HAART – Highly active anti-retroviral therapy, PM 10 – Particulate matter 10 micro meters, PM 2.5 - Particulate matter 2.5 micro meters, COPD – Chronic obstructive pulmonary disease, CVD – Cardiovascular disease, DM – Diabetes mellitus, HTN - Hypertension)

Confounding factors are those which exert an influence over both exposure and outcome in an epidemiological study. In light to COVID-19, Vitamin D deficiency cannot be held responsible solely for increased susceptibility of the disease. Along with the deficiency, the following factors also contribute to the COVID-19 disease:

  1. Age and sex

  2. Social factors

  3. Health risk factors

  4. Medical variables (comorbidities and number of medications)

  5. Environmental factors

These are described briefly in pictorial representation. (Figure 3)

Figure 4

Mechanism of action of Vitamin D supplements

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/7b49bd2f-7cc8-4acc-9758-e8110ae04e88image4.png

Vitamin D Supplementation

For every 4 ng/mL increase in vitamin D level there is 7% chance of lowering infection.41 So, vitamin D supplementation would be useful in reducing the viral replication and in treatment of patients with corona virus disease. Daily or weekly Vitamin D dose between 20μg and 50μg showed to reduce respiratory tract infections.42 When supplemented with a dose of 100μg/daily for one year showed reduced risk of infection.43 Hence, patients with Covid infection, belonging to a high risk group, should be checked for vitamin D status as it boosts immune system and regulates Renin angiotensin system. However in high doses, it is inhibitory to immune system.44 The goal of the supplementation is to maintain the vitamin D level between 40-60 ng/ml. People at risk of COVID-19 are recommended to take 10,000 IU/day of vitamin D3 for a few weeks followed by 5000 IU/day as suggested by Gant et al.45

Some of the limitations of the supplementation include:

  1. The patients, who report late, present with severe symptoms in the hyper-inflammatory stage, making it onerous for VD3 to exert its anti-viral effect.

  2. It is arduous to potentially specify the effect of a micro-nutrient over other concurrently given potent anti-inflammatory such as Dexamethasone in severe cases.46

Clinical Trials

Few studies have been conducted to prove the efficacy of vitamin D3 supplementation as a therapeutic measure or as an adjuvant in COVID-19 affected patients. The purpose of these studies and their findings are summarized as follows:

A short term, randomized, placebo controlled study by Rastogi et al. was done to find the outcome of high dose, oral vitamin D supplementation on SARS-COV2 viral clearance. The results have shown that a daily supplementation of 60,000IU for 14 days helped in achieving a serum concentration of greater than 50ng/ml in 75% of the study population. High dose of supplementation, therapeutically, lead to SARS-COV2 RNA negative in 41.7% participants and was also found useful for viral clearance.47

A quasi experimental study conducted by Cedric Annweiler et al. in France conclusively stated that regardless of all confounding factors involved, regular bolus supplementation of vitamin D was linked with less severe infection and better survival rate in hospitalized frail elderly patients.48

To the contrary, a double blind randomized control study conducted at Sao Paula, Brazil stated that vitamin D supplementation did not confer any therapeutic gain as a measure of improvising the severe illness and thereby does not have any effect on length of stay in hospital.49

A Pilot study done by Castillo et al. evaluated established that a high dose of Calcifediol - a metabolite of Vitamin D, when supplemented in patients with COVID-19 significantly reduced the need for ICU treatment of patients and also the severity of infection amongst Spanish population.50

In a clinical case series by Ohaegbulam et al., New York, Vitamin D supplementation was given to 4 COVID-19 hospitalized patients who were Vitamin D deficient. The cases displayed the following key findings- doubling levels of Vitamin D concentration in serum thereby gaining Vitamin D improvement state, lowering in CRP and ESR levels, and undetectable concentrations of IL-6; Also it has substantiated that achieving and maintaining adequate levels of Vitamin D can be looked upon as an effective strategy to decrease potential risks of secondary bacterial infection caused by interleukin inhibitors.51

Limitation

Majority of the study shows only the association between vitamin D and COVID-19. Only few studies show the underlying cause of the disease and deficiency.

Conclusion

Vitamin D’ anti-inflammatory, antiviral and immunomodulatory effect makes it a safe and inexpensive therapy to combat and overcome corona virus disease. However, trials have to be conducted to set up the therapeutic levels for mild, moderate and severely affected covid patients.

Disclosure Statement

The authors declare no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Acknowledgements

We would like to acknowledge Mr. Vignesh, the Digital manager for designing the figures in our manuscript.

References

1 

JI Pedersen Vitamin D requirement and setting recommendation levels - current Nordic viewNutr Rev2008661659

2 

RG Mehta X Peng F Alimirah G Murillo R Mehta Vitamin D and breast cancer: emerging conceptsCancer Lett2012126398

3 

J Welsh Vitamin D and cancer: integration of cellular biology, molecular mechanisms and animal modelsScand J Clin Lab Invest Suppl201224310311

4 

CS Maxwell ET Carbone RJ Wood Better newborn vitamin D status lowers RSV-associated bronchiolitis in infantsNutr Rev201270954852

5 

M Hoffmann H Kleine-Weber S Schroeder N Kruger T Herrler S Erichsen Cell SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitorCell2020181227180

6 

M Rondanelli A Miccono S Lamburghini I Avanzato A Riva P Allegrini Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common ColdsEvid Based Complement Alternat Med201820185813095

7 

M Infante C Ricordi J Sanchez MJ Clare-Salzler N Padilla V Fuenmayor Influence of vitamin d on islet autoimmunity and beta-cell function in type 1 diabetesNutrients2019119218510.3390/nu11092185

8 

R Bouillon C Marcocci G Carmeliet D Bikle J H White B Dawson-Hughes Skeletal and extraskeletal actions of vitamin D: current evidence andoutstanding questionsEndocrine Rev201940110951

9 

MT Zdrenghea H Makrinioti C Bagacean A Bush SL Johnston LA Stanciu Vitamin D modulation of innate immune responses to respiratory viral infectionsRev Med Virol201727110.1002/rmv.1909

10 

B Prietl G Treiber TR Pieber K Amrein Vitamin D and immune functionNutrients20135250221

11 

TT Wang FP Nestel V Bourdeau Y Nagai Q Wang J Liao Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expressionJ Immunol2004173290912

12 

CL Greiller AR Martineau Modulation of the immune response to respiratory viruses by vitamin DNutrients20157424070

13 

JM Yuk DM Shin HM Lee CS Yang HS Jin KK Kim Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidinCell Host Microbe2009623143

14 

J Bacchetta JJ Zaritsky JL Sea RF Chun TS Lisse K Zavala Suppression of iron-regulatory hepcidin by vitamin DJ Am Soc Nephrol20142556472

15 

S Hansdottir MM Monick SL Hinde N Lovan DC Look GW Hunninghake Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defenseJ Immunol200818170909

16 

XJ Guo PG Thomas New fronts emerge in the influenza cytokine stormSemin Immunopathol20173954150

17 

J Watkins Preventing a covid-19 pandemicBMJ2020368m810

18 

G Isaia R Giorgino GB Rini Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factorsOsteoporos Int20031457782

19 

JL Greger Effect of Variations in Dietary Protein, Phosphorus, Electrolytes and Vitamin D on Calcium and Zinc Metabolism: Nutrient Interactions198820528https://agris.fao.org/agris-search/search.do?recordID=US8845059

20 

AJW Velthuis SHE Worm AC Sims RS Baric EJ Snijder MJ Hemert Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLoS Pathog201061110.1371/journal.ppat.1001176

21 

K Yin DK Agrawal Vitamin D and inflammatory diseasesJ Inflamm Res201476987

22 

DN Roffe-Vazquez AS Huerta-Delgado EC Castillo JR Villarreal-Calderón AM Gonzalez-Gil C Enriquez Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up studyInt J Mol Sci201920225811

23 

P Mehta DF Mcauley M Brown E Sanchez RS Tattersall JJ Manson COVID-19: consider cytokine storm syndromes and immunosuppressionLancet20203951022910334

24 

AL Darling KR Ahmadi KA Ward NC Harvey AC Alves DK Dunn-Waters Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls MedRxiv202010.1101/2020.04.29.20084277

25 

M Alipio Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-19)SSRN Elect J200910.2139/ssrn.3571484

26 

DD Smet KD Smet P Herroelen S Gryspeerdt Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemicsInfect Dis202010.1101/2020.05.01.20079376

27 

P Raharusun S Priambada C Budiarti Patterns of COVID-19 Mortality and Vitamin D: An Indonesian Study2020https://emerginnova.com/patterns-of-covid19-mortality-and-vitamin-d-an-indonesian-study/

28 

B Bikdeli MV Madhavan D Jimenez T Chuich I Dreyfus E Driggin COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow upJ Am Coll Cardiol202075295073

29 

JM Rhodes S Subramanian E Laird G Griffin RA Kenny Perspective: vitamin D deficiency and COVID-19 severity-plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosisJ Intern Med202010.1111/joim.13149

30 

HK Biesalski Vitamin D deficiency and co-morbidities in COVID-19 patients-A fatal relationshipNfs J2020201021

31 

A Pizzini M Aichner S Sahanic A Böhm A Egger G Hoermann Impact of vitamin d deficiency on COVID-19-A prospective analysis from the CovILD registryNutrients20201292775

32 

A Abrishami N Dalili PM Torbati R Asgari M Arab-Ahmadi B Behnam Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective studyEur J Nutr20203019

33 

A Radujkovic T Hippchen S Tiwari-Heckler S Dreher M Boxberger U Merle Vitamin D deficiency and outcome of COVID-19 patientsNutrients20201292757

34 

V Baktash T Hosack N Patel S Shah P Kandiah K Abbeele Vitamin D status and outcomes for hospitalised older patients with COVID-19Postgrad Med J20219711494427

35 

JL Faul CP Kerley B Love E O'Neill C Cody W Tormey Vitamin D deficiency and ARDS after SARS-CoV-2 infectionIr Med J 2020113584

36 

RT Pinzon AW Pradana Vitamin D deficiency among patients with COVID-19: case series and recent literature reviewTrop Med Health20204817

37 

A Jain R Chaurasia NS Sengar M Singh S Mahor S Narain Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markersSci Reports20201018

38 

JL Hernández D Nan M Fernandez-Ayala M García-Unzueta MA Hernández-Hernández M López-Hoyos Vitamin D status in hospitalized patients with SARS-CoV-2 infectionJ Clin Endocrinol Metab20211063e134353

39 

DO Meltzer TJ Best H Zhang T Vokes V Arora J Solway Association of vitamin D status and other clinical characteristics with COVID-19 test resultsJAMA Netw Open202039e2019722

40 

A D’avolio V Avataneo A Manca J Cusato A DeNicolò R Lucchini 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2Nutrients20201251359

41 

DJ Berry K Hesketh C Power E Hyppönen Vitamin D status has a linear association with seasonal infections and lung function in British adultsBr J Nutr2011106143340

42 

AR Martineau DA Jolliffe RL Hooper L Greenberg JF Aloia P Bergman Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant dataBMJ2017356i6583

43 

P Bergman AC Norlin S Hansen RS Rekha B Agerberth L Björkhem-Bergman Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomized and double-blind intervention studyBMJ Open201226e001663

44 

M Mangin R Sinha K Fincher Inflammation and vitamin D: the infection connectionInflkamm Res20146380311

45 

WB Grant H Lahore SL Mcdonnell CA Baggerly CB French JL Aliano Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and DeathsNutrients202012988

46 

AR Martineau NG Forouhi Vitamin D for COVID-19: a case to answerLancet Diabetes Endocrinol202087356

47 

A Rastogi A Bhansali N Khare V Suri N Yaddanapudi N Sachdeva Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)Postgrad Med J202010.1136/postgradmedj-2020-139065

48 

C Annweiler B Hanotte CG Eprevier JM Sabatier L Lafaie T Célarier Vitamin D and survival in COVID-19 patients: A quasi-experimental studyJ Steroid Biochem Mol Biol2020204105771

49 

IH Murai AL Fernandes LP Sales AJ Pinto KF Goessler CSC Duran Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical TrialJAMA202132511105360

50 

ME Castillo LM Costa JM Barrios JF Díaz JL Miranda R Bouillon Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical studyJ Steroid Biochem Mol Biol2020203105751

51 

KC Ohaegbulam M Swalih P Patel MA Smith R Perrin Vitamin D supplementation in COVID-19 patients: a clinical case seriesAm J Ther2020e485



jats-html.xsl

© This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article type

Review Article


Article page

179-185


Authors Details

Akshaya Sridhar, Monisha Mohan, Kalai Selvi Rajendiran, Priyanka Sekar, Anand Shanker Singh, Selvaraj Nambiar, Ananda Vayaravel Cassinadane*


Article History

Received : 20-08-2021

Accepted : 07-09-2021

Available online : 08-10-2021


Article Metrics


View Article As

 


Downlaod Files

   








Wiki in hindi